Gut microbiome, probiotics, gut-brain axis, and digestive health
324 articles
New research in Cell Metabolism explores how gut bacteria and their metabolites regulate immune checkpoint blockade efficacy in cancer patients.
A 12-month RCT finds a lactobacilli probiotic not only failed to prevent bone loss but accelerated it slightly vs. placebo.
A primate single-nucleus study identifies NCoR1 decline as a conserved gut aging mechanism — and shows metformin can restore it.
A completed pilot trial explores whether a cholesterol-lowering probiotic can improve cardiometabolic health in people with celiac disease.
A microbiota-derived short-chain fatty acid stops Candida colonization by acidifying fungal cells — a finding with major implications for immunocompromised patients.
New research reveals how microbiota-produced SCFAs directly block Candida albicans growth, pointing to prebiotic therapies for immunocompromised patients.
A Nature Neuroscience study reveals gut microbes regulate intestinal motor circuits through sex hormone metabolism, linking the microbiome to gut motility.
New research reveals uric acid actively causes obesity by depleting a key gut bacterium and unleashing intestinal fat absorption — not just a bystander.
The British Society of Gastroenterology's expert panel takes stock of 10 years of microbiome advances and where the field is headed.
New research reveals gut microbes reactivate excreted androgens via enzymes, directly regulating enteric neurons that control gut motility.
A completed clinical trial tests whether a prebiotic blend can boost Akkermansia muciniphila and support weight management in metabolic syndrome.
A newly identified gut fungus suppresses Candida overgrowth via amino acid competition — and restricting dietary threonine reduces colitis in mice.
